Tipsep-Cortisol Ria Diagnostic Kit
Nuclear Diagnostics
FDA Clearance Information
The tipsep-cortisol ria diagnostic kit was cleared by the FDA via the 510(k) pathway on June 17, 1987. Manufactured by Nuclear Diagnostics, it is classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- In vitro quantitative measurement of cortisol in human biological samples.
- Use as an aid in the evaluation of adrenal function.
Clinical Applications
- Laboratory measurement of cortisol concentrations.
- Evaluation of suspected disorders of adrenal cortisol production.
- Assessment of cortisol results in the clinical workup of adrenal function.
Reported off-label uses
- Research measurement of cortisol in studies of stress, endocrine physiology, and cortisol-related disorders.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- This is an in vitro diagnostic assay, not an implantable or therapeutic device.
- The kit uses radioactive reagents and must be handled, stored, and disposed of according to the product labeling and applicable radiation-safety requirements.
- Results can be affected by specimen type, collection timing, medications, binding-protein changes, and assay interference; interpretation should follow the laboratory’s validated procedures.
- It is not an MRI-compatible device because it is a laboratory assay rather than equipment used in or on the patient during MRI.
- The kit does not have a patient-contacting size, vessel compatibility requirement, or procedural implant duration.
Frequently Asked Questions
What are the clinical indications for tipsep-cortisol ria diagnostic kit?
The device is indicated for measuring cortisol levels to diagnose adrenal disorders such as Cushing's syndrome and Addison's disease.
What outcomes have been reported in clinical studies?
Studies report high sensitivity and specificity in cortisol measurement, aiding in the diagnosis of adrenal disorders.
What complications have been reported?
Safety data indicate potential assay interference from iodinated contrast media, but no significant adverse events have been reported.